171 related articles for article (PubMed ID: 22440657)
1. [Clinical usefulness of the reticulocyte hemoglobin equivalent in chronic hemodialysis patients].
Eckhardt A; Freiberg MA; de la Fuente J; Douthat W; Capra R
Rev Fac Cien Med Univ Nac Cordoba; 2011; 68(2):51-5. PubMed ID: 22440657
[TBL] [Abstract][Full Text] [Related]
2. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
Davidkova S; Prestidge TD; Reed PW; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency.
Miwa N; Akiba T; Kimata N; Hamaguchi Y; Arakawa Y; Tamura T; Nitta K; Tsuchiya K
Int J Lab Hematol; 2010 Apr; 32(2):248-55. PubMed ID: 19624802
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Reticulocyte Hemoglobin Equivalent in Management of Regular Hemodialysis Patients with Iron Deficiency Anemia.
Dalimunthe NN; Lubis AR
Rom J Intern Med; 2016; 54(1):31-6. PubMed ID: 27141568
[TBL] [Abstract][Full Text] [Related]
5. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent.
Sany D; El Shahawi Y; Taha J
Saudi J Kidney Dis Transpl; 2020; 31(6):1263-1272. PubMed ID: 33565438
[TBL] [Abstract][Full Text] [Related]
7. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients.
Ng HY; Chen HC; Pan LL; Tsai YC; Hsu KT; Liao SC; Chuang FR; Chen JB; Lee CT
Nephron Clin Pract; 2009; 111(4):c247-52. PubMed ID: 19293593
[TBL] [Abstract][Full Text] [Related]
8. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.
Garzia M; Di Mario A; Ferraro E; Tazza L; Rossi E; Luciani G; Zini G
Lab Hematol; 2007; 13(1):6-11. PubMed ID: 17353176
[TBL] [Abstract][Full Text] [Related]
9. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
[TBL] [Abstract][Full Text] [Related]
10. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of iron deficiency in patients undergoing hemodialysis.
Buttarello M; Pajola R; Novello E; Rebeschini M; Cantaro S; Oliosi F; Naso A; Plebani M
Am J Clin Pathol; 2010 Jun; 133(6):949-54. PubMed ID: 20472854
[TBL] [Abstract][Full Text] [Related]
12. Percentage of hypochromic erythrocytes and reticulocyte hemoglobin equivalent predictors of response to intravenous iron in hemodialysis patients.
Urrechaga E; Boveda O; Aguayo FJ; de la Hera P; Muñoz RI; Gallardo I; Escanero JF
Int J Lab Hematol; 2016 Aug; 38(4):360-5. PubMed ID: 27160837
[TBL] [Abstract][Full Text] [Related]
13. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status.
Chinudomwong P; Binyasing A; Trongsakul R; Paisooksantivatana K
J Clin Lab Anal; 2020 Jun; 34(6):e23225. PubMed ID: 32043622
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-dialysis stage and in patients on peritoneal dialysis].
Eguchi A; Tsuchiya K; Tsukada M; Nitta K
Nihon Jinzo Gakkai Shi; 2010; 52(2):132-40. PubMed ID: 20415234
[TBL] [Abstract][Full Text] [Related]
17. Reticulocyte hemoglobin equivalent in a thalassemia-prevalent area.
Kadegasem P; Songdej D; Lertthammakiat S; Chuansumrit A; Paisooksantivatana K; Mahaklan L; Wongwerawattanakoon P; Tangbubpha N; Sirachainan N
Pediatr Int; 2019 Mar; 61(3):240-245. PubMed ID: 30593711
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability.
Urrechaga E; Borque L; Escanero JF
Int J Lab Hematol; 2013 Apr; 35(2):144-9. PubMed ID: 23033935
[TBL] [Abstract][Full Text] [Related]
19. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states.
Brugnara C; Schiller B; Moran J
Clin Lab Haematol; 2006 Oct; 28(5):303-8. PubMed ID: 16999719
[TBL] [Abstract][Full Text] [Related]
20. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
Schoorl M; Schoorl M; Nubé MJ; Bartels PC
Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
